Groups/days
Treatment/Dose (mg/mL)
Intervals
Zero time 7 14 21 28
Normal Control 223.4
± 4.07
230.5
± 5.11
234.9
± 2.75
242.4
± 5.60
251
± 4.33
Control + CAMBA (25mg/kg) 215.9
± 5.64
221.86
± 4.58
228.16
± 6.80
234.25
± 4.07
239.66
± 7.62
Control +CAMBA (50mg/kg) 219.68
± 4.73
224.19
± 6.05
229.33
± 5.17
238.48
± 4.95
240.32
± 2.44
Diabetic Control 210.25
± 3.78
195.49
± 5.36*
190.82
± 7.08*
185.55
± 4.15*
179.50
± 6.04*
Diabetic + CAMBA (25mg/kg) 213.59
± 2.26
216.60
± 3.57**
219.40
± 4.05**
222.00
± 6.23**
225.83
± 4.15**
Diabetic +CAMBA (50mg/kg) 216.30
± 2.94
221.5
± 4.22**
226.05
± 3.66**
229.14
± 5.02**
234.40
± 6.18**
Diabetic +Glibenclamide(5mg/kg) 214.15
± 6.43
218.09
± 4.72**
220.93
± 6.40**
223.69
± 4.55**
226.35
± 5.20**
Values are given as mean ± SD for groups of eight animals each. Values are statistically significant at *P<0.01. Diabetic control rats were compared with normal control rats. Experimental groups were compared with diabetic control
Table 2: Effect of CAMBA on body weight in normal and diabetic rats.